Minque, Baby Boy .

HRN: 24-32-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2024
CEFOTAXIME 500MG (VIAL)
02/02/2024
02/08/2024
IVT
100mg
Q12
Psnb
Waiting Final Action 
02/02/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/02/2024
02/08/2024
IVT
32mg
OD
Psnb
Waiting Final Action 
02/06/2024
OXACILLIN 500MG (VIAL)
02/06/2024
03/03/2024
IV
55mg
Q8hours
Sepsis
Checking Final Appropriateness 
02/08/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/08/2024
02/24/2024
IVT
200mg/ml
Q8
Meconium Aspiration Syndrome
Checking Final Appropriateness 
02/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/08/2024
02/15/2024
IV
15mg
Q12h
Necrotizing Enterocolitis
Checking Final Appropriateness 
02/14/2024
OXACILLIN 500MG (VIAL)
02/14/2024
02/16/2024
IVT
55mg
Q8hrd
Neonatal Sepsis
Waiting Final Action 
02/14/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
02/14/2024
02/21/2024
TOPICAL
1%
As Needed
Rashes
Waiting Final Action 
02/17/2024
FLUCONAZOLE 50MG (CAP)
02/17/2024
02/24/2024
ORAL
25mg
Q24
Meconium Aspiration Syndrome
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: